Industry News

FDA Warns Hospira Again, This Time in India

June 5, 2013

Hospira has received another warning letter from the US FDA following an inspection at the company’s India plant in October 2012. Read the full story

Latest from Industry News

Sentio BioSciences invests $10.6M to expand Missouri manufacturing site

Novo Nordisk invests $115M to expand quality control lab testing at China site

Ofichem acquires Avivia to bolster complex formulation services

Alvotech buys Ivers-Lee to boost assembly, packaging capacity for biosimilars